Abstract
The global impact of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) is increasing and traditional preventative ‘safe sex’ strategies do not seem to be slowing the spread of this virus. With an efficacious vaccine at least a decade away, the only strategy to avoid the ever-increasing cost of highly active antiretroviral therapy (HAART) is to develop new methods that prevent virus transmission. Microbicides are topicallyapplied molecules that disrupt the HIV cycle and block infection. This review discusses the current state of the art in microbicide development, looking at the most clinically advanced microbicides and those at earlier development stages based on their mechanisms of action. The socioeconomic impact of microbicide use is also considered, as this will determine whether microbicides are taken up and used consistently by the target population.
Keywords: Microbicide, HIV/AIDS, surfactant, antiretroviral, combination microbicide, umbrella compound, developing country, socioeconomic impact
Current Pharmaceutical Design
Title: Can Microbicides Turn the Tide Against HIV?
Volume: 16 Issue: 4
Author(s): Koreen Ramessar, Maite Sabalza, Bruna Miralpeix, Teresa Capell and Paul Christou
Affiliation:
Keywords: Microbicide, HIV/AIDS, surfactant, antiretroviral, combination microbicide, umbrella compound, developing country, socioeconomic impact
Abstract: The global impact of human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) is increasing and traditional preventative ‘safe sex’ strategies do not seem to be slowing the spread of this virus. With an efficacious vaccine at least a decade away, the only strategy to avoid the ever-increasing cost of highly active antiretroviral therapy (HAART) is to develop new methods that prevent virus transmission. Microbicides are topicallyapplied molecules that disrupt the HIV cycle and block infection. This review discusses the current state of the art in microbicide development, looking at the most clinically advanced microbicides and those at earlier development stages based on their mechanisms of action. The socioeconomic impact of microbicide use is also considered, as this will determine whether microbicides are taken up and used consistently by the target population.
Export Options
About this article
Cite this article as:
Ramessar Koreen, Sabalza Maite, Miralpeix Bruna, Capell Teresa and Christou Paul, Can Microbicides Turn the Tide Against HIV?, Current Pharmaceutical Design 2010; 16 (4) . https://dx.doi.org/10.2174/138161210790232202
DOI https://dx.doi.org/10.2174/138161210790232202 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
p38 Mitogen-Activated Protein Kinase: A Critical Node Linking Insulin Resistance and Cardiovascular Diseases in Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Immune Response Towards Snake Venoms
Inflammation & Allergy - Drug Targets (Discontinued) Immunomodulatory Effects of Vitamin D in Influenza Infection
Current Immunology Reviews (Discontinued) Inflammation in Hypertension: Current Therapeutic Approaches
Current Pharmaceutical Design Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review
Current Cancer Drug Targets Targeting the Bombesin/Gastrin-Releasing Peptide Receptor to Treat Sepsis
Recent Patents on Anti-Infective Drug Discovery Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunological Aspects of Scorpion Toxins: Current Status and Perspectives
Inflammation & Allergy - Drug Targets (Discontinued) Meet Our Editorial Board Member
Current Cancer Drug Targets A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction
Current Pharmaceutical Design Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases
Current Drug Targets Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design Current Experimental Therapy for Alzheimers Disease
Current Neuropharmacology microRNA Decay: Refining microRNA Regulatory Activity
MicroRNA Preclinical Models of Graves’ Disease and Associated Secondary Complications
Current Pharmaceutical Design Antioxidant Activity of Plant Phenols: Chemical Mechanisms and Biological Significance
Current Organic Chemistry Cytochrome P450 Pharmacogenetics in Drug Development: In Vitro Studies and Clinical Consequences
Current Drug Metabolism Design, Characterization and Pre-Clinical Evaluation of Aceclofenac Loaded Algino-gelatin Microspheres for Targeted Drug Delivery
Drug Delivery Letters Molecular Switch of AhR in Repression or Activation of Stem Cell Signaling
Current Signal Transduction Therapy Interventions to Prevent Long-Term Consequences of Bronchiolitis
Current Respiratory Medicine Reviews